
Ask a doctor about a prescription for MEROPENEM LDP LABORATORIOS TORLAN 500 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION
Patient Information Leaflet
Meropenem LDP-Laboratorios Torlan 500 mg powder for solution for injection and infusion EFG
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
Meropenem LDP-Laboratorios Torlan belongs to a group of medicines called carbapenem antibiotics. It works by killing bacteria that can cause serious infections.
Antibiotics are used to treat bacterial infections and do not work for viral infections such as flu or the common cold. It is important that you follow the instructions regarding dose, administration interval, and treatment duration as indicated by your doctor. Do not store or reuse this medicine. If you have any leftover antibiotic after finishing treatment, return it to the pharmacy for proper disposal. Do not throw medicines down the drain or in the trash. |
Meropenem LDP-Laboratorios Torlan is used to treat the following infections in adults and children from 3 months of age:
? Infection affecting the lungs (pneumonia)
? Bronchial and lung infections in patients with cystic fibrosis
? Complicated urinary tract infections
? Complicated infections in the abdomen
? Infections that you can acquire during and after childbirth
? Complicated skin and soft tissue infections
? Acute bacterial infection of the brain (meningitis)
Meropenem LDP-Laboratorios Torlan may be used to treat patients with low white blood cell counts (neutropenia) who have fever that is suspected to be due to a bacterial infection.
Meropenem LDP-Laboratorios Torlan can be used to treat bacterial infection of the blood that may be associated with one of the aforementioned infections.
Do not use Meropenem LDP-Laboratorios Torlan
Warnings and precautions
Talk to your doctor, pharmacist, or nurse before starting Meropenem LDP-Laboratorios Torlan:
You may develop a positive response to a test (Coombs test) that indicates the presence of antibodies that can destroy red blood cells. Your doctor will discuss this with you.
You may develop signs and symptoms of severe skin reactions (see section 4). If this happens, inform your doctor or nurse immediately so that they can treat the symptoms.
Liver problems
Tell your doctor or pharmacist if you notice yellowing of the skin and eyes, itching of the skin, dark-colored urine, or light-colored stools. This may be a sign of liver problems that your doctor should check.
If you are in any of these situations, or if you have doubts, consult your doctor before using meropenem.
Other medicines and Meropenem LDP-Laboratorios Torlan
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
This is because meropenem may affect the way some medicines work, and some of these may affect meropenem.
In particular, tell your doctor or nurse if you are taking any of the following medicines:
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine. It is preferable to avoid using meropenem during pregnancy.
Your doctor will decide whether you should use Meropenem LDP-Laboratorios Torlan.
It is very important that you inform your doctor if you are breastfeeding or plan to breastfeed before receiving treatment with meropenem. A small amount of this medicine may pass into breast milk. Therefore, your doctor will decide whether you should use Meropenem LDP-Laboratorios Torlan during breastfeeding.
Driving and using machines
No studies have been conducted on the effects on the ability to drive and use machines. Meropenem LDP-Laboratorios Torlan has been associated with headache and tingling or numbness in the skin (paresthesia). Any of these side effects could affect your ability to drive or use machines. Meropenem LDP-Laboratorios Torlan may cause involuntary muscle movements, which can cause the body to shake rapidly and uncontrollably (convulsions). This is usually accompanied by a loss of consciousness. Do not drive or use machines if you experience this side effect.
Meropenem LDP-Laboratorios Torlan contains sodium
Meropenem LDP-Laboratorios Torlan 500 mg contains approximately 45 mg of sodium (main component of table/cooking salt) in each vial. This is equivalent to 2.25% of the maximum recommended daily dietary intake of sodium for an adult.
Follow the instructions for administration of this medicine exactly as indicated by your doctor or pharmacist. If you are in doubt, consult your doctor or pharmacist again.
Use in adults
? The dose depends on the type of infection you have, the area of the body where it is located, and its severity. Your doctor will decide what dose you need.
? The normal dose in adults is between 500 mg (milligrams) and 2 g (grams). You will usually be given a dose every 8 hours. However, if your kidneys do not work well, you may receive the dose less frequently.
Use in children and adolescents
? The dose for children over 3 months and up to 12 years is decided using the child's age and weight. The normal dose is between 10 mg and 40 mg of Meropenem LDP-Laboratorios Torlan per kilogram (kg) of the child's weight. You will usually be given a dose every 8 hours. Children who weigh over 50 kg will be given an adult dose.
How to use Meropenem LDP-Laboratorios Torlan
? Meropenem LDP-Laboratorios Torlan will be administered to you as an injection or infusion into a large vein.
? Meropenem LDP-Laboratorios Torlan will usually be administered by your doctor or nurse.
? However, some patients, parents, or caregivers are trained to administer Meropenem LDP-Laboratorios Torlan at home. The instructions for this are found in this leaflet (in the section called "Instructions for administering Meropenem LDP-Laboratorios Torlan to yourself or another person at home"). Follow the instructions for administration of Meropenem LDP-Laboratorios Torlan exactly as indicated by your doctor. Consult your doctor if you have doubts.
? Your injection should not be mixed with or added to solutions that contain other medicines.
? The injection can last approximately 5 minutes or between 15 and 30 minutes. Your doctor will tell you how Meropenem LDP-Laboratorios Torlan is administered.
? Injections should usually be administered at the same time every day.
If you use more Meropenem LDP-Laboratorios Torlan than you should
If you accidentally use more doses than prescribed, contact your doctor or go to the nearest hospital immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount administered.
If you forget to use Meropenem LDP-Laboratorios Torlan
If you forget an injection, you should receive it as soon as possible. However, if it is almost time for your next injection, do not receive the missed one.
Do not use a double dose (two injections at the same time) to make up for missed doses.
If you stop using Meropenem LDP-Laboratorios Torlan
Do not stop using Meropenem LDP-Laboratorios Torlan until your doctor tells you to.
If you have any other questions about the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Severe allergic reactions
If you have a severe allergic reaction, stop using Meropenem LDP-Laboratorios Torlan and go to a doctor immediately. You may need urgent medical treatment. The symptoms can include:
? Severe rash, itching, or hives on the skin.
? Swelling of the face, lips, tongue, or other parts of the body.
? Shortness of breath, wheezing, or difficulty breathing.
Damage to red blood cells(frequency not known)
The symptoms include:
? Shortness of breath when you do not expect it.
? Red or brown urine.
If you notice any of the above, go to a doctor immediately.
Other possible side effects:
Common(may affect up to 1 in 10 people)
? Abdominal pain (stomach pain).
? Nausea.
? Vomiting.
? Diarrhea.
? Headache.
? Skin rash, itching of the skin.
? Pain and inflammation.
? Increased platelet count in the blood (found in a blood test).
? Changes in blood tests, including tests that show how your liver is working.
Uncommon(may affect up to 1 in 100 people)
? Changes in your blood. These include a decrease in the number of platelets (which can make you bruise more easily), an increase in some white blood cells, a decrease in other white blood cells, and an increase in the amount of a substance called "bilirubin". Your doctor may perform blood tests periodically.
? Changes in blood tests, including tests that show how your kidneys are working.
? Tingling sensation (numbness).
? Infections of the mouth or vagina caused by a fungus (thrush).
? Inflammation of the intestine with diarrhea.
? Pain in the veins where meropenem is injected.
? Other changes in your blood. The symptoms include frequent infections, fever, and sore throat. Your doctor may perform blood tests periodically.
? Sudden onset of a severe skin rash or blistering or peeling of the skin. This may be associated with high fever and joint pain.
Rare(may affect up to 1 in 1,000 people)
? Seizures (convulsions).
Frequency not known(cannot be estimated from the available data)
? Severe hypersensitivity reactions with fever, skin rash, and changes in blood tests that control liver function (increase in liver enzyme values) and increase in a type of white blood cell (eosinophilia) and enlarged lymph nodes. These may be symptoms of a multi-organ sensitivity disorder known as DRESS syndrome.
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects that are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https//www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children. Store below 30 ºC.
Do not use this medicine after the expiry date that appears on the packaging after EXP. The expiry date is the last day of the month indicated.
Injection
After reconstitution: The reconstituted solutions for injection should be used immediately. The time between the start of reconstitution and the end of the injection should not exceed:
Infusion
After reconstitution: The reconstituted solutions for infusion should be used immediately.
The time between the start of reconstitution and the end of the infusion should not exceed:
.
From a microbiological point of view, unless the method of opening/reconstitution/dilution excludes the risk of microbial contamination, the product should be used immediately. If not used immediately, the storage times and conditions before use are the responsibility of the user and should not exceed the times indicated above for chemical and physical stability during use, whichever is shorter.
Do not freeze the reconstituted solution.
Medicines should not be disposed of via wastewater or household waste. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines that are no longer needed. This will help protect the environment.
The active ingredient is meropenem. Each vial contains meropenem trihydrate equivalent to 500 mg of anhydrous meropenem
Appearance of the Product and Container Content
White to light yellow powder.
Type III glass vial
This medication is supplied in packages of 10 vials
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
LDP LABORATORIOS TORLAN, S.A.
Ctra. Barcelona 135
08290 Cerdanyola del Vallès (Barcelona)
Spain
Manufacturer
ACS DOBFAR S.p.A.
Nucleo Industriale S. Atto
64100 Teramo
Italy
Local Representative
Laphysan, SAU
C/ Anabel Segura nº11. Edificio A. Planta 4. Puerta D.
28108 Alcobendas (Madrid)
Spain
Date of the Last Revision of this Prospectus:June 2025
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).
------------------------------------------------------------------------------------------------------------------------
This information is intended only for healthcare professionals:
Instructions for Administering Meropenem LDP-Laboratorios Torlan to Yourself or Another Person at Home
Some patients, parents, and caregivers are trained to administer Meropenem LDP-Laboratorios Torlan at home.
Warning – You should only administer this medication to yourself or another person at home after a doctor or nurse has trained you.
How to Prepare this Medication
The amount of liquid you need is shown in the table below:
Dose of Meropenem LDP-Laboratorios Torlan | Amount of "Water for Injectable Preparations" needed for dilution |
500 mg (milligrams) | 10 ml (milliliters) |
1 g (gram) | 20 ml |
Administration of the Injection
You can administer this medication through a peripheral intravenous catheter, or through a port or central line.
Administration of Meropenem LDP-Laboratorios Torlan through a Peripheral Intravenous Catheter
Administration of Meropenem LDP-Laboratorios Torlan through a Port or Central Line
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for MEROPENEM LDP LABORATORIOS TORLAN 500 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION – subject to medical assessment and local rules.